Clinical Trial Update: SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the SVRd regimen for newly diagnosed multiple myeloma with extramedullary disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• SVRd

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING